Abstract:The number of elderly people with cognitive impairment is expected to increase dramatically due to aging of the population. It is expected that by 2050, 115 million people worldwide will have some form of cognitive impairment, including mild cognitive impairment and Alzheimer disease. 1 Ferri C.P. Sousa R. Albanese E. et al. Executive summary. in: Prince M. Jackson J. World Alzheimer Report 2009. Alzheimer’s Disease International, London2009: 1-22 Google Scholar For China, it is reported that there were 9.19 million cases of any cognitive impairment in mainland China alone in 2010 and the numbers are expected to rise in the coming decades. 2 Chan K.Y. Wang W. Wu J.J. et al. Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990–2010: A systematic review and analysis. Lancet. 2013; 381: 2016-2023 Abstract Full Text Full Text PDF PubMed Scopus (529) Google Scholar Obviously, cognitive impairment will be a new epidemic in the future unless major public health policies and preventive measures target brain health. Brain Health: The Importance of Recognizing Cognitive Impairment: An IAGG Consensus ConferenceJournal of the American Medical Directors AssociationVol. 16Issue 9PreviewCognitive impairment creates significant challenges for patients, their families and friends, and clinicians who provide their health care. Early recognition allows for diagnosis and appropriate treatment, education, psychosocial support, and engagement in shared decision-making regarding life planning, health care, involvement in research, and financial matters. An IAGG-GARN consensus panel examined the importance of early recognition of impaired cognitive health. Their major conclusion was that case-finding by physicians and health professionals is an important step toward enhancing brain health for aging populations throughout the world. Full-Text PDF

A Framework of Biomarkers for Brain Aging: a Consensus Statement by the Aging Biomarker Consortium

A Biomarker Framework for Cardiac Aging: the Aging Biomarker Consortium Consensus Statement

Dementia in China: epidemiology, clinical management, and research advances

A Framework of Biomarkers for Vascular Aging: a Consensus Statement by the Aging Biomarker Consortium

An evaluation of aging measures: from biomarkers to clocks

The Aging Biomarker Consortium represents a new era for aging research in China

A Biomarker Framework for Liver Aging: the Aging Biomarker Consortium Consensus Statement

Development and Validation of Two Composite Aging Measures Using Clinical Biomarkers in the Chinese Population

Beijing Aging Brain Rejuvenation Initiative: aging with grace

Progress in the study of aging marker criteria in human populations

Development and Validation of 2 Composite Aging Measures Using Routine Clinical Biomarkers in the Chinese Population: Analyses from 2 Prospective Cohort Studies.

The mechanisms, hallmarks, and therapies for brain aging and age-related dementia

Early prevention of cognitive impairment in the community population: The Beijing Aging Brain Rejuvenation Initiative

Connectome-based Predictive Modelling of Ageing, Overall Cognitive Functioning and Memory Performance.

Blood‐based Biomarkers of Alzheimer's Disease: Standardization and Comprehensiveness

Molecular and phenotypic biomarkers of aging [version 1; referees: 3 approved]

Determining a multimodal aging clock in a cohort of Chinese women

Biomarkers of Aging and Relevant Evaluation Techniques: A Comprehensive Review

Epigenomic, Transcriptome And Image-Based Biomarkers Of Aging

Biomolecular Markers of Brain Aging

Brain Health: A Chinese Geriatrician's Viewpoint.